Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dominik Fischer

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
Investigative Ophthalmology & Visual Science|January 21, 2025
Safety of Human USH1C Transgene Expression Following Subretinal Injection in Wild-Type PigsPeter Kiraly, Joshua Klein, Immanuel P Seitz, et al.
JAMA Ophthalmology|August 30, 2019
Efficacy and Safety of Retinal Gene Therapy Using Adeno-Associated Virus Vector for Patients With Choroideremia: A Randomized Clinical TrialM Dominik Fischer, G Alex Ochakovski, Benjamin Beier, et al.
Retina (Philadelphia, Pa.)|October 12, 2018
CHANGES IN RETINAL SENSITIVITY AFTER GENE THERAPY IN CHOROIDEREMIAM Dominik Fischer, G Alex Ochakovski, Benjamin Beier, et al.
American Journal of Ophthalmology|February 4, 2024
A Prospective, Observational, Non-interventional Clinical Study of Participants With Choroideremia: The NIGHT StudyRobert E Maclaren, Byron L Lam, M Dominik Fischer, et al.
Retina (Philadelphia, Pa.)|October 17, 2024
THE FIGHT INHERITED RETINAL BLINDNESS! PROJECT: A New Treatment Outcome and Natural History Registry for Inherited Retinal DiseaseMatthew P Simunovic, Anthony T Moore, John Grigg, et al.
The British Journal of Ophthalmology|August 18, 2025
Safety and vision outcomes of subretinal gene supplementation therapy in <i>PDE6A</i>-associated retinitis pigmentosa: a non-randomised controlled trialFelix F Reichel, M Dominik Fischer, Katarina Stingl, et al.
Experimental Eye Research|July 2, 2026
Subretinal injection in the USH1CR31* pig model leads to chorioretinal atrophy that limits evaluation of efficacy of an AAV-mediated gene therapyRuslan Nyshchuk, Joshua Klein, Immanuel P Seitz, et al.
The British Journal of Ophthalmology|October 10, 2018
Macular spatial distribution of preserved autofluorescence in patients with choroideremiaAmir H Hariri, Michael S Ip, Aniz Girach, et al.
JAMA Ophthalmology|May 1, 2020
Safety and Vision Outcomes of Subretinal Gene Therapy Targeting Cone Photoreceptors in Achromatopsia: A Nonrandomized Controlled TrialM Dominik Fischer, Stylianos Michalakis, Barbara Wilhelm, et al.
JAMA Ophthalmology|October 15, 2020
Clinical Phenotype and Course of PDE6A-Associated Retinitis Pigmentosa Disease, Characterized in Preparation for a Gene Supplementation TrialLaura Kuehlewein, Ditta Zobor, Sten Olof Andreasson, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Investigative Ophthalmology & Visual Science|January 21, 2025
Safety of Human USH1C Transgene Expression Following Subretinal Injection in Wild-Type PigsPeter Kiraly, Joshua Klein, Immanuel P Seitz, et al.
JAMA Ophthalmology|August 30, 2019
Efficacy and Safety of Retinal Gene Therapy Using Adeno-Associated Virus Vector for Patients With Choroideremia: A Randomized Clinical TrialM Dominik Fischer, G Alex Ochakovski, Benjamin Beier, et al.
Retina (Philadelphia, Pa.)|October 12, 2018
CHANGES IN RETINAL SENSITIVITY AFTER GENE THERAPY IN CHOROIDEREMIAM Dominik Fischer, G Alex Ochakovski, Benjamin Beier, et al.
American Journal of Ophthalmology|February 4, 2024
A Prospective, Observational, Non-interventional Clinical Study of Participants With Choroideremia: The NIGHT StudyRobert E Maclaren, Byron L Lam, M Dominik Fischer, et al.
Retina (Philadelphia, Pa.)|October 17, 2024
THE FIGHT INHERITED RETINAL BLINDNESS! PROJECT: A New Treatment Outcome and Natural History Registry for Inherited Retinal DiseaseMatthew P Simunovic, Anthony T Moore, John Grigg, et al.
The British Journal of Ophthalmology|August 18, 2025
Safety and vision outcomes of subretinal gene supplementation therapy in <i>PDE6A</i>-associated retinitis pigmentosa: a non-randomised controlled trialFelix F Reichel, M Dominik Fischer, Katarina Stingl, et al.
Experimental Eye Research|July 2, 2026
Subretinal injection in the USH1CR31* pig model leads to chorioretinal atrophy that limits evaluation of efficacy of an AAV-mediated gene therapyRuslan Nyshchuk, Joshua Klein, Immanuel P Seitz, et al.
The British Journal of Ophthalmology|October 10, 2018
Macular spatial distribution of preserved autofluorescence in patients with choroideremiaAmir H Hariri, Michael S Ip, Aniz Girach, et al.
JAMA Ophthalmology|May 1, 2020
Safety and Vision Outcomes of Subretinal Gene Therapy Targeting Cone Photoreceptors in Achromatopsia: A Nonrandomized Controlled TrialM Dominik Fischer, Stylianos Michalakis, Barbara Wilhelm, et al.
JAMA Ophthalmology|October 15, 2020
Clinical Phenotype and Course of PDE6A-Associated Retinitis Pigmentosa Disease, Characterized in Preparation for a Gene Supplementation TrialLaura Kuehlewein, Ditta Zobor, Sten Olof Andreasson, et al.
Pageof 13